Monday, January 22, 2018

Big Drugmakers Pay Big Prices for Promising Biotechs

Lofty premiums Celgene and Sanofi shelled out in Monday’s biotech deals show companies’ need for quick revenue as generic competition poses threats.

from WSJ.com: US Business http://ift.tt/2Dz17Tc
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)